BMY Bristol Myers Squibb Co

  1. Stocks
  2. Healthcare
  3. NYSE: BMY

Price (delayed)

$77.65

Market cap

$165.32B

P/E Ratio

27.34

Dividend/share

$2.06

EPS

$2.84

Enterprise value

$197.92B

Bristol Myers Squibb is an American pharmaceutical company, headquartered in New York City. Bristol Myers Squibb manufactures prescription pharmaceuticals and biologics in several therapeutic areas, including cancer, HIV/AIDS, cardiovascular disease, ...

Highlights
Bristol Myers Squibb's gross profit has increased by 17% YoY and by 2.6% from the previous quarter
The company's revenue rose by 10% YoY
The quick ratio has decreased by 18% YoY and by 14% QoQ
Bristol Myers Squibb's equity has decreased by 16% YoY and by 12% from the previous quarter
Sector: Healthcare
Industry: Drug Manufacturers - General
Website: https://www.bms.com/
Peers: PFE MRK LLY ABBV

Key stats

What are the main financial stats of BMY
Market
Shares outstanding
2.13B
Market cap
$165.32B
Enterprise value
$197.92B
Valuations
Price to earnings (P/E)
27.34
Price to book (P/B)
5.36
Price to sales (P/S)
3.6
EV/EBIT
27.35
EV/EBITDA
11.09
EV/Sales
4.21
Earnings
Revenue
$46.96B
EBIT
$7.24B
EBITDA
$17.84B
Free cash flow
$15.14B
Per share
EPS
$2.84
Free cash flow per share
$6.95
Book value per share
$14.49
Revenue per share
$21.54
TBVPS
$19.47
Balance sheet
Total assets
$103.03B
Total liabilities
$71.39B
Debt
$44.97B
Equity
$31.58B
Working capital
$7.3B
Liquidity
Debt to equity
1.42
Current ratio
1.32
Quick ratio
1.03
Net debt/EBITDA
1.83
Margins
EBITDA margin
38%
Gross margin
79.6%
Net margin
13.3%
Operating margin
15.4%
Efficiency
Return on assets
5.8%
Return on equity
17.7%
Return on invested capital
13.2%
Return on capital employed
9%
Return on sales
15.4%
Dividend
Dividend yield
2.65%
DPS
$2.06
Payout ratio
72.5%

BMY stock price

How has the Bristol Myers Squibb stock price performed over time
Intraday
0.96%
1 week
1.78%
1 month
0.18%
1 year
18.62%
YTD
24.54%
QTD
6.33%

Financial performance

How have Bristol Myers Squibb's revenue and profit performed over time
Revenue
$46.96B
Gross profit
$37.39B
Operating income
$7.26B
Net income
$6.25B
Gross margin
79.6%
Net margin
13.3%
BMY's net margin has soared by 192% year-on-year but it is down by 12% since the previous quarter
Bristol Myers Squibb's gross profit has increased by 17% YoY and by 2.6% from the previous quarter
The operating margin has declined by 12% since the previous quarter
The net income has declined by 11% since the previous quarter

Growth

What is Bristol Myers Squibb's growth rate over time

Valuation

What is Bristol Myers Squibb stock price valuation
P/E
27.34
P/B
5.36
P/S
3.6
EV/EBIT
27.35
EV/EBITDA
11.09
EV/Sales
4.21
Bristol Myers Squibb's EPS has decreased by 10% QoQ
BMY's P/B is 30% above its last 4 quarters average of 4.1 and 6% above its 5-year quarterly average of 5.0
Bristol Myers Squibb's equity has decreased by 16% YoY and by 12% from the previous quarter
The price to sales (P/S) is 12% more than the last 4 quarters average of 3.2 but 6% less than the 5-year quarterly average of 3.8
The company's revenue rose by 10% YoY

Efficiency

How efficient is Bristol Myers Squibb business performance
Bristol Myers Squibb's return on sales has decreased by 11% QoQ
Bristol Myers Squibb's ROA has decreased by 8% from the previous quarter
BMY's return on invested capital is down by 8% since the previous quarter
The ROE has contracted by 7% from the previous quarter

Dividends

What is BMY's dividend history
Dividend details
DPS
$2.06
Dividend yield
2.65%
Payout ratio
72.5%
Recent dividends

Financial health

How did Bristol Myers Squibb financials performed over time
BMY's total assets is 44% greater than its total liabilities
The quick ratio has decreased by 18% YoY and by 14% QoQ
Bristol Myers Squibb's current ratio has decreased by 15% YoY and by 13% from the previous quarter
BMY's debt is 42% greater than its equity
Bristol Myers Squibb's equity has decreased by 16% YoY and by 12% from the previous quarter
The company's debt to equity rose by 15% YoY and by 15% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.